Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
3.450
+0.170 (5.18%)
At close: Nov 5, 2025, 4:00 PM EST
3.470
+0.020 (0.58%)
After-hours: Nov 5, 2025, 6:48 PM EST
Verrica Pharmaceuticals Market Cap
Verrica Pharmaceuticals has a market cap or net worth of $32.59 million as of November 5, 2025. Its market cap has decreased by -52.27% in one year.
Market Cap
32.59M
Enterprise Value
56.08M
1-Year Change
-52.27%
Ranking
Category
Stock Price
$3.45
Market Cap Chart
Since June 15, 2018, Verrica Pharmaceuticals's market cap has decreased from $436.56M to $32.59M, a decrease of -92.54%. That is a compound annual growth rate of -29.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 30.98M | -51.13% |
| Dec 31, 2024 | 63.40M | -79.41% |
| Dec 29, 2023 | 307.91M | 172.47% |
| Dec 30, 2022 | 113.01M | -55.17% |
| Dec 31, 2021 | 252.07M | -15.33% |
| Dec 31, 2020 | 297.71M | -27.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 15, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 798.54B |
| Johnson & Johnson | 451.43B |
| AbbVie | 376.05B |
| UnitedHealth Group | 301.09B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 213.67B |